MedTrace Logo

Dopamine Versus Norepinephrine Under General Anesthesia

NCT04536194 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-10-22

No results posted yet for this study

Summary

Participants under general anesthesia will be randomly treated with an adjusted dose dopamine or norepinephrine to elevate 10% of mean arterial pressure. Systemic hemodynamic data is recorded by PRAM and the change of cardiac index is compared between groups.

Conditions

  • Anesthesia
  • Infant
  • Congenital Heart Disease
  • Hemodynamic Instability

Interventions

DRUG

norepinephrine

to treat hypotension under general anesthesia with norepinephrine

DRUG

dopamine

to treat hypotension under general anesthesia with dopamine

Sponsors & Collaborators

  • Children's Hospital of Fudan University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
1 Month
Max Age
12 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-10
Primary Completion
2021-08-31
Completion
2021-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04536194 on ClinicalTrials.gov